Human rabies mRNA vaccine (Zhuhai Lifanda/Amy Biovaccine)

人用狂犬病mRNA疫苗（珠海丽凡达/艾美疫苗）

Report date: 2023/06/12 11:32:31

Base Information

Drug NameHuman rabies mRNA vaccine (Zhuhai Lifanda/Amy Biovaccine)
Drug Alias Name人用狂犬病mRNA疫苗
ClassificationVaccines > Application > Prophylactic vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II)
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRabies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesZhuhai Lifanda Biotechnology Co LtdAim Vaccine Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZhuhai Lifanda Biotechnology Co LtdAim Vaccine Co Ltd
Inactive CompaniesN/A
Active IndicationsRabies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A